HomeInsights52 Week Low Stocks

Jubilant Pharmova Ltd 52 Week Low

Jubilant Pharmova Ltd 52 Week Low

stocks purchased

₹ 1.4 Cr

Volume transacted

stocks purchased

11.5 K

stocks traded

Last Updated time: 05 Nov 14:05 PM

Image

Jubilant Pharmova Ltd

NSE: JUBLPHARMA

YEARLOW

392

Last updated on: Nov 04, 2024

Key Highlights

  • The 52 Week Low of Jubilant Pharmova Ltd is ₹ 392 as of 04 Nov 24.

Company Fundamentals for Jubilant Pharmova Ltd

No data available

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Jubilant Pharmova Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
04 Nov 20241252.35
01 Nov 20241264
31 Oct 20241212.35
30 Oct 20241133.35
29 Oct 20241108.15
28 Oct 20241096.35
25 Oct 20241056.1
24 Oct 20241108.4
23 Oct 20241138.85
22 Oct 20241127

Asset Value vs Market Value of Jubilant Pharmova Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Jubilant Pharmova Ltd

No data available

* All values are in crore

Historical Net Profit of Jubilant Pharmova Ltd

No data available

* All values are in crore

Jubilant Pharmova Ltd News Hub

News

Jubilant Pharmova to conduct board meeting

Jubilant Pharmova will hold a meeting of the Board of Directors of the Company on 25 Octob...

Read more

18 Oct 202410:41

News

Jubilant Pharmova gains as Washington unit gets VAI classification from USFDA

The United States Food & Drug Administration (USFDA) conducted an audit of the facility fr...

Read more

11 Sep 202410:52

News

Jubilant Pharmova Ltd leads gainers in 'A' group

Morepen Laboratories Ltd, La Opala RG Ltd, AGI Greenpac Ltd and Gujarat Alkalies & Chemica...

Read more

09 Sep 202412:00

News

Volumes soar at Jubilant Pharmova Ltd counter

Alembic Pharmaceuticals Ltd, Doms Industries Ltd, EPL Ltd, Anand Rathi Wealth Ltd are amon...

Read more

09 Sep 202414:30

News

Jubilant Biosys signs and issues a put option offer to Pierre Fabre Laboratories

Jubilant Biosys Innovative Research Services,, Singapore (JBIRSPL), subsidiary of Jubilant...

Read more

16 Aug 202418:41

News

Volumes soar at Jubilant Pharmova Ltd counter

Firstsource Solutions Ltd, Adani Energy Solutions Ltd, Sapphire Foods India Ltd, Lloyds Me...

Read more

01 Aug 202414:30

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for 52 Week Low of Jubilant Pharmova Ltd

Why is it important to track the 52-week low of Jubilant Pharmova Ltd stocks?

Investors should monitor the 52-week low of Jubilant Pharmova Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Jubilant Pharmova Ltd stocks hitting a 52-week low?

Factors leading to Jubilant Pharmova Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Jubilant Pharmova Ltd stocks when they hit a 52-week low?

Buying Jubilant Pharmova Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Jubilant Pharmova Ltd stocks?

Investors should monitor the 52-week low of Jubilant Pharmova Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Jubilant Pharmova Ltd stock at their 52-week low?

An investor can analyze the reasons for the Jubilant Pharmova Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Jubilant Pharmova Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Jubilant Pharmova Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Jubilant Pharmova Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*